These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 23893443)

  • 1. Dystonia rating scales: critique and recommendations.
    Albanese A; Sorbo FD; Comella C; Jinnah HA; Mink JW; Post B; Vidailhet M; Volkmann J; Warner TT; Leentjens AF; Martinez-Martin P; Stebbins GT; Goetz CG; Schrag A
    Mov Disord; 2013 Jun; 28(7):874-83. PubMed ID: 23893443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum neurotoxins for the treatment of focal dystonias: Review of rating tools used in clinical trials.
    Del Sorbo F; Albanese A
    Toxicon; 2015 Dec; 107(Pt A):89-97. PubMed ID: 26365917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations.
    Colosimo C; Martínez-Martín P; Fabbrini G; Hauser RA; Merello M; Miyasaki J; Poewe W; Sampaio C; Rascol O; Stebbins GT; Schrag A; Goetz CG
    Mov Disord; 2010 Jul; 25(9):1131-42. PubMed ID: 20310033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scales to assess sleep impairment in Parkinson's disease: critique and recommendations.
    Högl B; Arnulf I; Comella C; Ferreira J; Iranzo A; Tilley B; Trenkwalder C; Poewe W; Rascol O; Sampaio C; Stebbins GT; Schrag A; Goetz CG
    Mov Disord; 2010 Dec; 25(16):2704-16. PubMed ID: 20931631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Empirical Comparison of Commonly Used Universal Rating Scales for Dystonia.
    Boz D; Kilic-Berkmen G; Perlmutter JS; Norris SA; Wright LJ; Klein C; Bäumer T; Löns S; Feuerstein JS; Mahajan A; Wagle-Shukla A; Malaty I; LeDoux MS; Ondo W; Pantelyat A; Frank S; Saunders-Pullman R; Jinnah HA
    Mov Disord Clin Pract; 2023 Dec; 10(12):1777-1786. PubMed ID: 38094647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Content overlap of 91 dystonia symptoms among the seven most commonly used cervical dystonia scales.
    Chrobak AA; Rusinek J; Dec-Ćwiek M; Porębska K; Siwek M
    Neurol Sci; 2024 Apr; 45(4):1507-1514. PubMed ID: 37910323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-operative evaluations for DBS in dystonia.
    Thobois S; Taira T; Comella C; Moro E; Bressman S; Albanese A
    Mov Disord; 2011 Jun; 26 Suppl 1():S17-22. PubMed ID: 21692107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson's disease.
    Evatt ML; Chaudhuri KR; Chou KL; Cubo E; Hinson V; Kompoliti K; Yang C; Poewe W; Rascol O; Sampaio C; Stebbins GT; Goetz CG
    Mov Disord; 2009 Apr; 24(5):635-46. PubMed ID: 19205066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinimetric testing of the comprehensive cervical dystonia rating scale.
    Comella CL; Perlmutter JS; Jinnah HA; Waliczek TA; Rosen AR; Galpern WR; Adler CA; Barbano RL; Factor SA; Goetz CG; Jankovic J; Reich SG; Rodriguez RL; Severt WL; Zurowski M; Fox SH; Stebbins GT
    Mov Disord; 2016 Apr; 31(4):563-9. PubMed ID: 26971359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease.
    Friedman JH; Alves G; Hagell P; Marinus J; Marsh L; Martinez-Martin P; Goetz CG; Poewe W; Rascol O; Sampaio C; Stebbins G; Schrag A
    Mov Disord; 2010 May; 25(7):805-22. PubMed ID: 20461797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of a Disease-Specific Oromandibular Dystonia Rating Scale (OMDRS).
    Yoshida K
    Front Neurol; 2020; 11():583177. PubMed ID: 33224096
    [No Abstract]   [Full Text] [Related]  

  • 12. Task force report: scales for screening and evaluating tremor: critique and recommendations.
    Elble R; Bain P; Forjaz MJ; Haubenberger D; Testa C; Goetz CG; Leentjens AF; Martinez-Martin P; Pavy-Le Traon A; Post B; Sampaio C; Stebbins GT; Weintraub D; Schrag A
    Mov Disord; 2013 Nov; 28(13):1793-800. PubMed ID: 24038576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wearing-off scales in Parkinson's disease: critique and recommendations.
    Antonini A; Martinez-Martin P; Chaudhuri RK; Merello M; Hauser R; Katzenschlager R; Odin P; Stacy M; Stocchi F; Poewe W; Rascol O; Sampaio C; Schrag A; Stebbins GT; Goetz CG
    Mov Disord; 2011 Oct; 26(12):2169-75. PubMed ID: 21780180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type B for cervical dystonia.
    Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrument.
    Müller J; Wissel J; Kemmler G; Voller B; Bodner T; Schneider A; Wenning GK; Poewe W
    J Neurol Neurosurg Psychiatry; 2004 May; 75(5):749-53. PubMed ID: 15090572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiety rating scales in Parkinson's disease: critique and recommendations.
    Leentjens AF; Dujardin K; Marsh L; Martinez-Martin P; Richard IH; Starkstein SE; Weintraub D; Sampaio C; Poewe W; Rascol O; Stebbins GT; Goetz CG
    Mov Disord; 2008 Oct; 23(14):2015-25. PubMed ID: 18792121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression rating scales in Parkinson's disease: critique and recommendations.
    Schrag A; Barone P; Brown RG; Leentjens AF; McDonald WM; Starkstein S; Weintraub D; Poewe W; Rascol O; Sampaio C; Stebbins GT; Goetz CG
    Mov Disord; 2007 Jun; 22(8):1077-92. PubMed ID: 17394234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of abobotulinumtoxinA liquid formulation in cervical dystonia: A randomized-controlled trial.
    Poewe W; Burbaud P; Castelnovo G; Jost WH; Ceballos-Baumann AO; Banach M; Potulska-Chromik A; Ferreira JJ; Bihari K; Ehler E; Bares M; Dzyak LA; Belova AN; Pham E; Liu WJ; Picaut P
    Mov Disord; 2016 Nov; 31(11):1649-1657. PubMed ID: 27653448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Zolpidem for Focal Dystonia After Neurosurgical Treatments: A Retrospective Cohort Study.
    Horisawa S; Kohara K; Ebise H; Nishitani M; Kawamata T; Taira T
    Front Neurol; 2022; 13():837023. PubMed ID: 35592470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensory tricks in primary blepharospasm and idiopathic cervical dystonia.
    Pandey S; Soni G; Sarma N
    Neurol India; 2017; 65(3):532-536. PubMed ID: 28488615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.